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ABSTRACT 
 
Wnt factors regulate neural stem cell development and neuronal connectivity. Here we 
investigated whether Wnt-3a and Wnt-3, expressed in the developing spinal cord, 
regulate proliferation and the neuronal differentiation of spinal cord neural precursors 
(SCNP). Wnt-3a promoted a sustained increase of SCNP proliferation, whereas Wnt-3 
enhanced SCNP proliferation transiently and increased neurogenesis through β-catenin 
signaling. Consistent with this, Wnt-3a and Wnt-3 differently regulate the expression of 
Cyclin-dependent kinase inhibitors. Furthermore, Wnt-3a and Wnt-3 stimulated neurite 
outgrowth in SCNP-derived neurons through ß-catenin and TCF4-dependent 
transcription. GSK-3ß inhibitors mimicked Wnt signaling and promoted neurite 
outgrowth in established cultures. We conclude that Wnt-3a and Wnt-3 signal through 
the canonical Wnt/β-catenin pathway to regulate different aspects of SCNP 
development. These findings may be of therapeutic interest for the treatment of 
neurodegenerative diseases and nerve injury.     
 
 
  
Key words: Neural stem cells, neuronal differentiation, Glycogen-synthase-kinase 
(GSK)-3ß, T-Cell Factor (TCF). 
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INTRODUCTION 
Neurons in the central nervous system (CNS) originate from embryonic neural 
precursors (NP) that proliferate at the subventricular zone. The maintenance, 
proliferation and differentiation of NPs are controlled by local signals at the stem cell 
niche. Wnt factors, a family of secreted glycoproteins, are important regulators of the 
proliferation, self-renewal, specification and differentiation of NPs in the CNS. Wnt-1 
and Wnt-3a control spinal cord dorsal interneuron specification (Murashov et al. 2005; 
Muroyama et al. 2002). Different Wnts distinctly regulate proliferation and 
neurogenesis of developing midbrain NPs (Andersson et al. 2008; Castelo-Branco et al. 
2003; Hirabayashi et al. 2004; Sousa et al. 2009). Wnt-7a directs the neuronal 
differentiation of cortical NPs (Hirabayashi et al. 2004). In addition, Wnt-3 regulates 
neurogenesis and Wnt-7a stimulates NP self-renewal and proliferation in the adult brain 
(Lie et al. 2005; Qu et al.).  
 
Wnts signal through three main pathways: the canonical Wnt/ß-catenin, the planar cell 
polarity and the calcium pathways (Ciani and Salinas 2005; Logan and Nusse 2004; 
Michaelidis and Lie 2008). In the canonical pathway, Wnts inhibit GSK-3ß, resulting in 
ß-catenin cytoplasmic stabilization, translocation to the nucleus and transcription by 
TCF/Lef factors of target genes. It is well documented that ß-catenin controls the 
expansion of NP populations through TCF activity (Chenn and Walsh 2002; Gulacsi 
and Anderson 2008; Zechner et al. 2003). Thus ß-catenin stabilization results in 
enlarged brain and spinal cord, whereas loss of  ß-catenin                                                           
reduces brain size and increases neuronal differentiation (Gulacsi and Anderson 2008; 
Woodhead et al. 2006). In agreement with these findings, the dorsal neural tube is 
reduced in size in Wnt-1/Wnt-3a mutant mice (Ikeya et al. 1997). In contrast, ß-catenin 
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stabilization increases neuronal differentiation of embryonic stem cells and NP 
(Castelo-Branco et al. 2004; Hirabayashi et al. 2004; Otero et al. 2004). Therefore, 
activation of the Wnt/ß-catenin signaling regulates proliferation and neuronal 
differentiation of NP highly depending on the cellular context and the developmental 
stage (Hirabayashi et al. 2004).    
 
Wnt-3a and Wnt-3 are expressed at dorsal areas of the developing spinal cord (Megason 
and McMahon 2002; Parr et al. 1993). Interestingly, Wnt-3 is also expressed around the 
ventricular zone as well as by lateral motoneurons (Krylova et al. 2002; Megason and 
McMahon 2002). It was proposed that dorsal Wnt-1 and Wnt-3a display mitogenic 
activities that shape the growth of the spinal cord (Megason and McMahon 2002). Here 
we investigated the roles of Wnt-3a and Wnt-3 factors in spinal cord neural precursor 
(SCNP) development. We found that both Wnt-3a and Wnt-3 promoted SCNP 
proliferation. Contrary to the mitogenic effect of Wnt-3a, Wnt-3 increased SCNP 
proliferation only transiently and enhanced neurogenesis. Furthermore, Wnt-3a and 
Wnt-3 stimulated neurite outgrowth. GSK-3ß inhibitors promoted or reduced neurite 
extension depending on the stage of neurite outgrowth, suggesting distinct roles of 
GSK-3ß during neurite development. Finally, ß-catenin and transcription by TCF4 were 
required for neurogenesis and neurite outgrowth induced by Wnts. These findings 
identify a role for canonical Wnt/ß-catenin signaling in SCNP-derived neuronal 
differentiation (including neurogenesis and neurite extension). Our results uncover 
similar actions of Wnt-3a and Wnt-3 during neurite outgrowth and a distinct regulation 
of cell cycle entry/exit by Wnt factors in SCNP proliferation/neurogenesis.         
Page 4 of 31
Journal of Neuroscience Research
Journal of Neuroscience Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 5 
MATERIAL AND METHODS 
Spinal cord neural precursor (SCNP) culture.  Mouse embryonic day 12.5-13 spinal 
cords were dissociated, after cleaning off the meninges, in phosphate buffer saline 
(PBS) plus 0.6% glucose using Pasteur pipettes (Wu et al. 2003). Cells were grown on 
plates coated with poly-2-hydroxyethyl-methacrylate (Sigma) in DMEM:F12 medium 
(Invitrogen) supplemented with B27 (Invitrogen) and basic Fibroblast Growth Factor 
(bFGF 20ng/ml; Invitrogen). The resulting neurospheres were grown for one to four 
weeks. Following neurosphere dissociation (Trypsin 0.25%; Invitrogen), cells plated on 
poly-D-lysine (10 µg/ml; Sigma) and laminin (4 µg/ml; Sigma) pre-coated glass 
coverslips or plastic wells in DMEM:F12 supplemented with B27 and 1% Fetal Calf 
Serum (FCS; Invitrogen) at 75-400 cells/mm2 in the absence of bFGF.  
 
Control and Wnt-3 conditioned media. Control Rat1B cells or stably expressing 
hemagglutinin(HA)-tagged Wnt-3 (provided by Dr. A. Munsterberg, Norwich) were 
maintained in DMEM (Invitrogen), 10% FCS and Geneticin 250 µg/ml (Invitrogen). To 
obtain control or Wnt-3 conditioned media (CM), cells were conditioned overnight in 
DMEM:F12 and B27 medium. CMs were centrifuged, diluted 1:1 with fresh medium 
and changed daily. The level of HA-Wnt-3 was monitored by Western-blot. Control 
experiments incubating SCNP with dialyzed sodium azide free anti-Wnt-3 antibodies 
(20 µg/ml; Santa Cruz;) together with Wnt-3 CM showed a blockade of the effects 
induced by Wnt-3 CM (data not shown), indicating that they were due to Wnt-3.  
 
Cell treatments. SCNP were stimulated with 50 ng/ml Bovine Serum Albumin (BSA), 
50 ng/ml Wnt-3a (R&D), control CM or Wnt-3 CM from the time of plating for 2-4 
days in vitro (DIV). The effect of Wnt-3a (50 ng/ml) was maintained within the 5-200 
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ng/ml range. Kenpaullone (Sigma; 15 µM) and BIO (6-bromoindirubin-3-oxime, 
Calbiochem; 1µM) were added from plating (DIV0-3) or from day 2 to day 3 (DIV2-3) 
and cultures were fixed at 3DIV. Actinomycin D (ActD, 5nM; Sigma) was added from 
plating and cultures fixed at 2DIV. Recombinant mouse Frizzled-8 cystein-rich 
domain/Fc chimera and Dikkopf-1 (R&D) were incubated at 100 or 300 ng/ml together 
with BSA, Wnt-3a, control CM or Wnt-3 CM from plating up to 4 DIV. All media was 
changed every other day, except for control and Wnt-3 CM that were changed daily. 
 
Flow cytometry analysis (FACS). SCNP stimulated with BSA/Wnt-3a or control/Wnt-
3 CM for 2DIV were trypsinized and fixed by resuspension in PBS and 70% ethanol (2 
hours, 4°C). Cells were incubated with 0.1% Triton X-100, 50 µg/ml of propidium 
iodide and 50 µg/ml of RNAse A (all from Sigma; 30 min, 37°C) before DNA content 
analysis on EPICS-XL flow cytometer (Coulter). 
 
Real time RT-PCR. Total RNA was isolated from SCNP cultures treated with BSA, 
Wnt-3, control or Wnt-3 CM up to 4DIV using the RNAeasy kit (Qiagen) including the 
DNAse digestion step. For reverse transcription, 0,5-1 µg of RNA was incubated 2 min 
at 90°C and the reaction was performed in 6.25 mM MgCl2, 2 mM dNTPs mix,  2.5 mM 
random hexamers, 20 U of RNAse inhibitor and  50 U of Multiscribe™ (all from 
Applied Biosystems; 10 min, 25°C/60 min, 42°C/5min, 95°C). RT- control samples 
were run in paral.lel without the addition of reverse transcriptase. Real-time RT-PCR 
was performed in triplicate using 1 µl of cDNA or RT- sample, Taqman Master Mix™ 
(Applied Biosystems) and FAM-labeled probes spanning different exons specific for 
mouse p57 (Mm00438170_m1), p27 (Mm00438168_m1) and β-actin (4352933E) as a 
housekeeping gene in a ABI Prism 7000 detection system (Applied Biosystems; 2 min, 
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50°C/10 min 95°C/15 sec, 95°C and 30 sec, 60°C repeated for 50 cycles). Relative 
mRNA expression levels were calculated by subtracting the value of the housekeeping 
gene and calculated as 2-∆∆Ct according to the manufacturer’s instructions.  
 
Antibodies. Antibodies against Nestin and NeuN were from Chemicon, anti-BrdU from 
Dako, anti-β-catenin from BD, anti-βIII-tubulin from Covance, anti-β-actin from Sigma 
and anti-EGFP/GFP  from Abcam. 
 
Bromodeoxiuridine (BrdU) incorporation, immunocytochemistry and 
morphometric measurements. BrdU 3.75 µg/ml was applied for 8 hours at 2DIV or 
4DIV before fixation with 4% paraformaldehyde. Immunocytochemistry was performed 
as described (David et al. 2008). For BrdU immunodetection, cells were permeabilized 
with 0.05% Triton X-100, incubated with 2N HCl (30 min, 37˚C) and neutralized with 
0.1M sodium tetraborate, pH=8,5 (2 min, RT) before blocking. Micrographs were 
obtained using an inverted Olympus IX70 microscope (10x, 0.3 NA and 20x, 0.4 NA) 
equipped with epifluorescence optics and a camera (Olympus OM-4 Ti).  
To calculate the percentage of total proliferation, the number of proliferating SCNP 
(BrdU and nestin-positive) was referred to the total number of cells stained by Hoechst. 
Alternatively, we calculated the percentage of BrdU incorporation in small neuroblasts 
(defined as nestin-positive SCNP with a cell body diameter of ~15 µm and displaying 
short neuritic-like processes) by counting small neuroblasts co-stained for BrdU and 
nestin referred to its total number. For neurogenesis, the number of ßIII-tubulin-
immunoreactive neurons was referred to the total number of cells stained by Hoechst at 
4DIV. The length of all ßIII-tubulin immunoreactive neurites was measured using 
Adobe Photoshop.  
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All plots represent average ± s.e.m. (n= 3-6 experiments; 80 cells counted or measured 
on average per condition and experiment). Significance was calculated by the Student T 
test (* p≤ 0.05, ** p≤ 0.01 and *** p≤ 0.001).  
 
shRNA expression by lentiviral infection. Specific 19 nucleotide sequences were 
chosen using RNAi design interfaces. Primers were designed against the sequences 
GGGTTCTGATGATATAAAT (shRNA1) and GTTTGTGCAGTTGCTTTAT 
(shRNA2) for mouse ß-catenin and cloned into pSUPER. A fragment containing the H1 
promoter for the RNA pol III and the shRNA sequence was subcloned into the 
pLVTHM plasmid (from Dr. D. Trono, Geneva). shRNA vectors were transfected into 
HEK293T together with psPAX2 and pMD2G and the viral pellet was obtained (David 
et al. 2008). Transfection efficiency (~ 90%) was analyzed by GFP expression driven by 
pLVTHM. SCNP were transduced with lentivirus expressing shRNAs 2 hours after 
plating and treated with BSA, Wnt-3a, control or Wnt-3 CM from 3DIV to 5DIV. Cells 
were fixed for GFP/ßIII-tubulin immunostaining and analyzed for neurogenesis or 
neurite outgrowth at 5DIV. Alternatively, cultures were lysed in 62.5 mM Tris-HCl, pH 
6,8 and 2% SDS for Western-blot.  
 
Nucleofection. Expression of EGFP alone or dominant-negative ∆N-TCF4-HA plus 
EGFP (3:1) was achieved using the Nucleofector (Amaxa) upon neurosphere 
disgregration. SCNP were sub-plated at 300 cells/mm2, treated 4 hours after plating 
with Wnts, fixed at 2DIV and immunostained for EGFP and HA (only cells co-
immunostained were measured for neurite length using the EGFP immunostaining).  
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RESULTS 
Wnt-3a and Wnt-3 increase SCNP proliferation  
The expression patterns of Wnt-3a and Wnt-3 in the developing spinal cord (Krylova et 
al. 2002; Megason and McMahon 2002; Parr et al. 1993) prompted us to study Wnt-3a 
and Wnt-3 signaling in mouse SCNP cultures. Since purified Wnt-3 is not available, we 
used CMs obtained from Rat1B-cells stably expressing Wnt-3 or control cells (Krylova 
et al. 2002; Purro et al. 2008). We first investigated a possible effect of Wnt-3a/Wnt-3 
in SCNP proliferation by FACS analysis. Wnt-3a and Wnt-3 treatments increased the 
percentage of cells in S phase compared to the corresponding control by 29% and 41% 
at 2DIV after 48h of Wnt stimulation (Fig. 1A). We also performed BrdU incorporation 
assays in SCNP cultures co-immunostained for nestin. Nestin immunostaining revealed 
heterogeneous morphologies of SCNP (Fig. 1B). Therefore, we calculated the 
percentage of cells that incorporated BrdU referred to all SCNP (total BrdU 
incorporation) and in small neuroblasts, defined as nestin-positive SCNP with a cell 
body diameter of ~15 µm and short neurite-like processes. Cultures treated with Wnt-3a 
and Wnt-3 up to 2DIV showed an increase of total BrdU incorporation of 68% and 
71%, respectively, compared to controls (Fig. 1C). Wnt-3a and Wnt-3 treatments also 
promoted BrdU incorporation in small neuroblasts by 19% and 20%, respectively, at 
2DIV (Fig. 1C). At 4DIV, Wnt-3a still increased BrdU incorporation (total BrdU 
incorporation by 86% and BrdU incorporation in small neuroblasts by 63% compared to 
control; Fig 1C). However, Wnt-3 did not affect BrdU incorporation (total or in small 
neuroblasts) compared to the control at 4DIV (Fig. 1C). These results suggest that Wnt-
3a maintains SCNP in a proliferative state, whereas Wnt-3 stimulates their proliferation 
only transiently.  
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To complement these findings, we performed real-time RT-PCR analysis of cyclin-
dependent kinase (Cdk) inhibitors (p57/kip2 and p27/kip1) expression from 4DIV 
control, Wnt-3a- or Wnt-3-treated SCNPs. Wnt-3a significantly decreased the 
expression of p57 and p27 vs control, whereas Wnt-3 increased their expression levels 
vs control samples (Fig. 1D). These findings are in agreement with the presence of 
putative TCF binding elements in the promoter region of the p57 and p27 (data not 
shown) and suggest that Wnt factors differently regulate SCNP proliferation/cell cycle 
exit at a transcriptional level.  
 
Wnt-3 increases neurogenesis from SCNP by canonical Wnt/ß-catenin pathway 
The transient increase in BrdU incorporation and the increased expression of Cdk 
inhibitors upon Wnt-3 stimulation suggested that SCNP exit the cell cycle after Wnt-3 
treatment. Therefore we studied neurogenesis in Wnt-treated SCNP. Wnt-3 increased by 
approximately 40% the proportion of neurons (immunolabelled for the early neuronal 
marker ßIII-tubulin) referred to the total number of cells at 4DIV (Fig. 2A, 2B and 4A), 
which also express the post-mitotic marker NeuU (Fig. 2D). The percentage of ßIII-
tubulin-immunoreactive neurons was not affected by Wnt-3a treatment (Fig. 2A), 
consistent with its effect inducing proliferation at 4DIV (Fig. 1C).  
 
In the canonical Wnt signaling, Wnt stimulation leads to GSK-3ß inhibition, β-catenin 
stabilization, nuclear translocation and transcriptional activation of TCF-target genes 
(Ciani and Salinas 2005). Treatment with the selective GSK-3ß inhibitor Bio (Sato et al. 
2004) increased the proportion of ßIII-tubulin-positive neurons (data not shown). To 
further investigate the implication of the canonical pathway, we studied the involvement 
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of β-catenin in the Wnt-induced neurogenesis by analyzing SCNP cultures expressing 
scrambled or β-catenin shRNAs. Wnt-3 but not Wnt-3a increased neurogenesis in 
SCNP expressing scrambled shRNA. Furthermore, the Wnt-3-dependent neurogenesis 
was blocked in SCNP expressing β-catenin shRNA (Fig. 2C). These results suggest that 
Wnt-3 promotes neurogenesis through the canonical Wnt/ß-catenin in SCNP. 
 
Wnt-3a and Wnt-3 increase neurite outgrowth of SCNP-derived neurons  
When analyzing βIII-tubulin immunostained SCNP-derived neurons, we noticed an 
effect of Wnts in neurite development (Fig. 2D). To investigate a role of Wnt-3a and 
Wnt-3 signaling on neurite outgrowth, we measured the length of all ßIII-tubulin-
positive neurites. Wnt-3a increased total neurite length by 23% and 32% at 2DIV and 
4DIV compared to the respective controls (Fig. 3A, 3C). Similarly, Wnt-3 also 
increased neurite length by about 25% and 59% at 2DIV and 4DIV, respectively, 
compared to the controls (Fig. 3B, 3D). These results demonstrate that Wnt-3a and 
Wnt-3 signaling stimulate neurite outgrowth in SCNP-derived neurons.  
 
Next we inhibited Wnt signaling using the Wnt inhibitor Frizzled-8 cysteine-rich-
domain/Fc chimera (Fz-8/Fc) that prevents Wnt binding to the Frizzled-LRP5/6 
receptor complex (Dann et al. 2001; Hsieh et al. 1999), and Dikkopf-1 (Dkk-1) that 
binds to canonical Wnt co-receptors LRP5/6 (Kikuchi et al. 2009). Treatment with Wnt-
3a and Fz-8/Fc with or without Dkk-1 did not modify neurogenesis above control levels 
in SCNP cultures (Fig. 4A). However, the proportion of βIII-tubulin-positive neurons 
following treatment with Wnt-3 and Fz-8/Fc or Wnt-3, Fz-8/Fc and Dkk-1 decreased 
compared to that of Wnt-3-stimulated cultures (Fig. 4A). Furthermore, total neurite 
length measurements following Wnt-3a and Wnt-3 treatments together with Fz-8/Fc or 
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Fz-8/Fc plus Dkk-1, respectively, showed in both cases a blockade in the Wnt-induced 
neurite extension of  SCNP-derived neurons (Fig. 4B). These results demonstrate the 
specificity of the effects promoted by Wnt-3a and Wnt-3 CM.  
 
GSK-3ß inhibition from plating or on established cultures differently affects 
neurite outgrowth  
To dissect the signaling pathway through which Wnt-3a and Wnt-3 promote neurite 
outgrowth in SCNP cultures, we first investigated the consequences of inhibiting GSK-
3ß. SCNP-derived neurons treated with the selective GSK-3ß inhibitor Bio (Sato et al. 
2004) or Kenpaullone that inhibits GSK-3ß, Cdks and other kinases (Bain et al. 2003) 
from 2DIV to 3DIV showed an increased total neurite length of 23% and 26%, 
respectively, compared to control (Fig. 5; DIV2-3). These results are similar to the 
stimulation of neurite extension promoted by Wnt-3a and Wnt-3 at 3DIV (data not 
shown), suggesting that Wnt-3a and Wnt-3 regulate neurite outgrowth by inhibiting 
GSK-3ß. Interestingly, inhibiting GSK-3ß from plating up to 3DIV with Bio or 
Kenpaullone resulted in an average inhibition of neurite outgrowth of 34% and 28%, 
respectively, compared to the control (Fig. 5; DIV0-3). The opposed results obtained 
upon GSK-3ß inhibition at different stages of neurite outgrowth in SCNP-derived 
neurons are in agreement with reported dual effects of GSK-3ß inhibition in axon 
formation vs axon elongation/branching (Garrido et al. 2007).  
 
ß-catenin and TCF4 are required for the Wnt-3a- and Wnt-3-induced neurite 
outgrowth  
A branch of the canonical Wnt pathway diverges at the level of GSK-3ß and regulates 
the microtubule cytoskeleton and the axon behavior independent of ß-catenin and of 
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transcriptional activation (Purro et al. 2008). To study the requirement of ß-catenin in 
the Wnt-induced neurite outgrowth, SCNP cultures were transduced with lentivirus for 
the expression of ß-catenin shRNAs. We obtained a reduction of ß-catenin total levels 
of ~20-30% with shRNA1-2 after 5DIV (Fig. 6A). Wnt-3a and Wnt-3 induced neurite 
outgrowth in SCNP expressing scrambled shRNA. However, the Wnt-induced neurite 
outgrowth was prevented in neurons expressing ß-catenin shRNAs (Fig. 6B-5C), 
indicating that ß-catenin is required for the neurite extension induced by Wnt-3a and 
Wnt-3 in SCNP-derived neurons.  
 
To study the involvement of gene transcription in the neurite outgrowth promoted by 
Wnt-3a and Wnt-3 we treated SCNP cultures with ActD. We used a concentration of 
ActD that did not affect neurite outgrowth in control neurons (Fig. 7A). However, the 
neurite outgrowth induced by Wnt-3a and Wnt-3 was blocked in ActD-treated cultures 
(Fig. 7A). We previously showed that ∆N-TCF4, which promoter can not bind ß-catenin 
(Roose et al. 1999), blocks the axon outgrowth induced by Wnt-3a in hippocampal 
neurons (David et al. 2008). We tested whether expression of dominant negative ∆N-
TCF4 could block the neurite outgrowth induced by Wnt-3a and Wnt-3. SCNP 
expressing EGFP treated with Wnt-3a or Wnt-3 for 48h displayed neurites ~ 30% 
longer than untreated controls (Fig. 7B). However, expression of ∆N-TCF4 blocked the 
increase in neurite length induced by Wnt-3a and Wnt-3 (Fig. 7B). These results 
demonstrate that transcription by TCF4 is downstream of ß-catenin in the stimulation of 
neurite outgrowth induced by Wnt-3a and Wnt-3 in spinal neurons. 
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DISCUSSION 
Here we studied the function of Wnt-3a and Wnt-3 in SCNP development. Despite high 
sequence homology, different Wnt-3a and Wnt-3 expression patterns (Krylova et al. 
2002; Megason and McMahon 2002; Roelink and Nusse 1991) suggest distinct 
functions. Wnt-3a stimulated SCNP proliferation in a continued manner up to 4DIV and 
decreased the expression of Cdk inhibitors. In contrast, Wnt-3 raised the expression of 
cell cycle inhibitors and increased neurogenesis through β-catenin. Furthermore, both 
Wnt-3a and Wnt-3 promoted neurite outgrowth in SCNP-derived neurons through 
activation of the Wnt/ß-catenin canonical pathway. These effects coincide in time with 
the proliferation/neurogenesis effects in SCNP cultures, suggesting that Wnts stimulate 
proliferation/neurogenesis of SCNP and at the same time promote neurite outgrowth on 
differentiating neurons. Our results highlight a different control of cell cycle entry/exit 
by Wnt-3a and Wnt-3 signaling and demonstrate the role of canonical Wnt signaling 
supporting neurite outgrowth in spinal neurons.   
   
Wnt signaling regulates embryonic and adult neurogenesis and neuronal connectivity 
(Ahmad-Annuar et al. 2006; Andersson et al. 2008; Castelo-Branco et al. 2003; Ciani 
and Salinas 2005; Chojnacki et al. 2009; Hirabayashi et al. 2004; Hirsch et al. 2007; 
Krylova et al. 2002; Kuwabara et al. 2009; Lee et al. 2004; Lie et al. 2005; Lu et al. 
2004; Michaelidis and Lie 2008; Muroyama et al. 2002; Muroyama et al. 2004; Sousa et 
al. 2009). Wnt-3 secreted by astrocytes regulates adult hippocampal neurogenesis 
through the Wnt/ß-catenin pathway (Lie et al. 2005). Contrary to Wnt-5a and Wnt-1 
that increase neurogenesis, Wnt-3a enhances proliferation from embryonic midbrain 
NPs (Castelo-Branco et al. 2003). In the developing spinal cord, Wnt-3a collaborates 
with Wnt-1 in the specification of dorsal interneurons (Lee et al. 2004; Muroyama et al. 
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2002). Dorsal Wnt-1/Wnt-3a signaling also suppress the ventral program instructed by 
Sonic Hedgehog (Shh) by controlling the expression of Gli3 repressor (Ulloa and Marti 
2009; Yu et al. 2008). Here we report that Wnt-3a and Wnt-3 increase BrdU 
incorporation in 2DIV SCNP. In agreement with a Wnt-3a mitogenic activity (Castelo-
Branco et al. 2003; Megason and McMahon 2002) Wnt-3a continued increasing SCNP 
proliferation at 4DIV, suggesting that Wnt-3a maintains SCNP cycling. In contrast, 
Wnt-3 did not affect SCNP proliferation and increased neurogenesis at 4DIV in a β-
catenin-dependent manner. What determines cell cycle entry/exit and differentiation by 
different Wnts remains to be fully elucidated. In vivo manipulation of ß-catenin levels 
showed that ß-catenin-mediated transcriptional activation controls cell cycle progression 
by regulating cyclin D1-D2 expression (Chenn and Walsh 2002; Megason and 
McMahon 2002; Woodhead et al. 2006; Zechner et al. 2003). However, a role for  ß-
catenin in neuronal specification and regulating neurogenin expression, has been also 
demonstrated (Hirabayashi et al. 2004; Woodhead et al. 2006; Yu et al. 2008). Recently, 
the proneural transcription factor NeuroD1 was identified as a novel Wnt target gene in 
adult neurogenesis (Kuwabara et al. 2009). Our results indicate that Wnt-3a and Wnt-3 
differently regulate Cdk inhibitor expression at 4DIV to control 
proliferation/differentiation. One possibility is that Wnt-3a and Wnt-3 signaling use 
different transcriptional co-activators resulting in the activation of proliferation or 
differention programs (Miyabayashi et al. 2007).  
 
The effects promoted by Wnt-3a and Wnt-3 CM were specific as they were inhibited by 
the Wnt antagonists Fz-8Fc and Dkk-1. However, the blockade of the Wnt-3-induced 
neurogenesis observed upon Fz-8Fc and Dkk-1 co-treatments was partial. Ryk cleavage 
and its intracellular C-terminal domain (ICD) translocation to the nucleus is required for 
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the Wnt-3-induced neurogenesis in the cortex (Lyu et al. 2008). Ryk expression in the 
spinal cord (Kamitori et al. 2002) would support a similar role in the SCNP-derived 
neurogenesis promoted by Wnt-3. However, Ryk ICD was suggested to signal 
independent of ß-catenin (Lyu et al. 2008) and we show that Wnt-3-induced 
neurogenesis from SCNP is ß-catenin-dependent. The possible contribution of Ryk to 
the Wnt-3-induced neurogenesis at the spinal cord remains to be studied.   
 
Which are the types of neurons generated by Wnt-3 signaling? SCNP differentiate into 
different neuron types according to the synthesis of different neurotransmitters (Kalyani 
et al. 1998). Recent studies demonstrate that Wnt signaling acts in coordination with 
Shh in the specification of ventral cell types at the neural tube Ulloa and Marti 2009; Yu 
et al. 2008). Wnt signaling generates dorsal and V2 cell fates at the expense of 
motoneurons (Yu et al. 2008). However, floor plate expression of Wnt-4/5 specifically 
promotes median motor column motoneuron identity (Agalliu et al. 2009). 
 
Dissection of the Wnt pathway activated by Wnt-3a/Wnt-3 in SCNP neurogenesis and 
neurite outgrowth implicates the Wnt/ß-catenin canonical pathway. GSK-3ß inhibitors 
mimicked Wnt-3 signaling as they stimulated neurite outgrowth on established cultures. 
Nevertheless, inhibition of GSK-3ß upon cell plating decreased the average neurite 
length. These findings suggest divergent roles for GSK3ß at early vs late stages of 
neurite specifation and outgrowth, in agreement with GSK3ß function in neuronal 
polarity and axon formation (Garrido et al. 2007; Kim et al. 2006). Furthermore, ß-
catenin was required for the Wnt-3 induced neurogenesis and the neurite outgrowth 
induced by Wnt-3a and Wnt-3. Although total ß-catenin levels decreased ~30 % upon 
expression of ß-catenin shRNAs, the Wnt-induced effects were completely prevented. 
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These results suggest that the ß-catenin nuclear signaling pool was mainly affected in 
SCNP-derived neurons and that the remaining ß-catenin is contributed by the cadherin-
bound ß-catenin and/or non-neuronal ß-catenin pools. Finally, ActD experiments and 
expression of ∆N-TCF4 demonstrated that transcription by TCF4 is needed for the Wnt-
3a/Wnt-3-promoted neurite outgrowth in spinal neurons. Together these results 
implicate a ß-catenin-dependent transcriptional regulation of TCF4 target genes to 
promote neurogenesis and neurite extension in spinal progenitors and neurons.  
 
Wnts regulate neurite development during the establishment of neuronal connections 
(Ciani and Salinas 2005). Wnt-3a increased neurite outgrowth in hippocampal, dorsal 
root ganglia and spinal neurons through TCF-driven gene transcription of target genes 
(present results) (David et al. 2008; Lu et al. 2004). Wnt-3 induces growth cone 
enlargement, axon branching and stops axon extension during the terminal 
differentiation of NT-3-dependent sensory axons (Krylova et al. 2002). Wnt-3a and 
Wnt-3 signal independent of ß-catenin and transcription during sensory axon 
remodeling (Purro et al. 2008). These findings contrast with the requirement of TCF4-
driven transcription for the Wnt3a- and Wnt-3-dependent neurite outgrowth in spinal 
neurons. It is possible that, by activating different signaling pathways, Wnts induce 
different neurite behaviors (outgrowth or growth cone pausing/remodeling).  
 
Wnt-3a mutant mice revealed that Wnt-3a is required for hippocampus formation (Lee 
et al. 2000) and for the expansion of CNS progenitors (Ikeya et al. 1997). However, the 
early embryonic lethality of Wnt-3 mutant mice (Liu et al. 1999) has hampered the in 
vivo analysis of the role(s) of Wnt-3 in spinal cord development. Importantly, genetic 
approaches demonstrated the in vivo role of Wnt signaling in the normal patterning of 
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the neural tube (Ulloa and Marti 2009; Yu et al. 2008). Ectopic expression of Wnt-3a in 
the chick spinal cord revealed that a gradient of dorsal midline Wnt-3a controls the size 
of the neural tube by positive regulation of cell cycle progression (Megason and 
McMahon 2002). In contrast, Wnt-3 that displays a dorsal broad domain of expression 
increased neuronal differentiation (Megason and McMahon 2002). This data supports 
our findings on the Wnt-3- and Wnt-3a-induced neurogenesis and proliferation, 
respectively, in cultured mouse SCNP. Moreover, we uncover a transient proliferation 
effect of Wnt-3 and demonstrate the stimulation of neurite outgrowth by Wnt-3a and 
Wnt-3 in SCNP-derived neurons. Thus, our results show that activation of the Wnt/ß-
catenin canonical pathway regulates cell cycle entry/exit and neurogenesis in neural 
precursors and leads to neuritogenesis in newborn neurons. This work illustrates the 
complexity of Wnt signaling (and of the canonical pathway), comprising several family 
members that perform partially redundant roles through the canonical pathway and 
induce different cell responses in a context and time-dependent manner (Yu et al. 2008). 
In addition, our findings suggest that components of the Wnt/ß-catenin pathway could 
be considered as therapeutic targets for the treatment of neurodegenerative diseases and 
nerve injury. Interestingly Wnt-3 is expressed in ependymal cells lining the central canal 
(Krylova et al. 2002), a cell population that could be considered the adult spinal neural 
stem cell (Chojnacki et al. 2009) and that responds to spinal cord injury (Meletis et al. 
2008). 
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Figure legends 
Figure 1. Wnt-3a and Wnt-3 produce a sustained or transient increase of SCNP 
proliferation. A) Increase in the percentage of SCNP in S phase in Wnt-treated cells 
normalized to controls at 2DIV. B) SCNP cultures treated with Wnt-3 and 
immunostained for nestin show increased numbers of neural precursors that incorporate 
BrdU at 2DIV (asterisks). Arrows point to small neuroblasts. (Bar= 65 µm). C) BrdU 
incorporation in small neuroblasts (left panels) and in total SCNP (right panels) show 
that Wnt-3a and Wnt-3 increase proliferation at 2DIV. However at 4DIV only Wnt-3a 
maintains SCNP proliferation. D) Expression levels of p57 and p27 Cdk inhibitors in 
SCNP treated with Wnt-3a or Wnt-3 normalized to the respective controls show 
decreased levels of p57 and p27 following Wnt-3a treatment and increased levels of p57 
upon Wnt-3 treatment at 4DIV. The ratio Wnt-3/Wnt-3a illustrates the increase of Cdk 
inhibitors expression by Wnt-3 compared to the effect of Wnt-3a. (* p≤ 0.05, ** p≤ 0.01 
and *** p≤ 0.001; n=3-5). 
 
Figure 2. Wnt-3 increases neurogenesis by canonical Wnt/ß-catenin signaling. A) 
Wnt-3, but not Wnt-3a, increases the percentage of ßIII-tubulin-positive SCNP-derived 
neurons at 4DIV. Wnt-3-treated SCNP cultures show increased number of ßIII-tubulin-
immunoreactive neurons referred to the total number of cells (stained by Hoechst) 
compared to control (Bar= 65 µm). B) The neurogenesis induced by Wnt-3 treatment 
(3-5DIV) in SCNP expressing scrambled shRNA is abolished by β-catenin shRNA. C) 
Wnt-3 increases neurite extension in SCNP-derived post-mitotic neurons, co-
immunostained for ßIII-tubulin and the transcription factor NeuN at 4DIV (Bar= 40 
µm) (* p≤ 0.05, ** p≤ 0.01 and *** p≤ 0.001; n=3-4). 
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 Figure 3.  Wnt-3a and Wnt-3 induce neurite outgrowth in SCNP-derived neurons. 
A, B) Wnt-3a and Wnt-3 increase neurite extension compared to controls at 2DIV and 
4DIV (Bar= 40 µm). C, D) Total neurite length values for control and Wnt-treated 
SCNP-derived neurons at 2DIV and 4DIV (** p≤ 0.01 and *** p≤ 0.001; n=4-6). 
.  
Figure 4. Effects of Dkk-1 and Fz-8/Fc on neurogenesis and neurite outgrowth at 
4DIV. A) Wnt-3 (bottom) but not Wnt-3a (top) increase neurogenesis (estimated as the 
% of βIII-tubulin-positive neurons) from SCNP, which is partially inhibited by high 
doses of Dkk-1 and Fz-8/Fc. B) Fz-8/Fc alone or together with Dkk-1 block the increase 
in neurite extension induced by Wnt-3a (top) and Wnt-3 (bottom), pointing at the 
specificity of the Wnt effects (* p≤0.05, **, p≤0.01, *** p≤0.001 when comparing to 
the corrresponding control; $ p≤0.05, $$ p≤0.01 when comparing to Wnt-treatment 
without Dkk-1 and Fz-8/Fc; n=3-4). Note the decreased neurite extension obtained upon 
Fz-8/Fc treatment in the absence of exogenous Wnt-3a, suggesting the role of 
endogenous Wnts in this process.  
 
Figure 5. GSK-3ß inhibition upon plating reduces neurite outgrowth, whereas 
later GSK-3ß inhibition mimics the Wnt-induced neurite extension in SCNP-
derived neurons. A) Schematic representation of the canonical Wnt/β-catenin pathway. 
Wnt binding to the Fz-LRP5/6 receptor complex recruits Dvl and results in the 
inhibition of GSK3-β, disassembly of the destruction complex involving GSK3-β, β-
catenin, APC, Axin and CK1 and accumulation of β-catenin in the cytosol that avoids 
degradation. β-catenin nuclear translocation and transcriptional regulation of TCF/LEF 
target genes. A branch of the pathway diverges at the level of GSK3-β and regulates the 
cytoskeleton independent of β-catenin (Ciani and Salinas 2005; Sanchez-Camacho and 
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Bovolenta 2009). B) SCNP were treated with Bio and Kenpaullone from plating (DIV0-
3) or overnight on pre-established adherent cultures (DIV2-3). Note the short processes 
of SCNP-derived neurons immunostained for βIII-tubulin treated with Bio from plating 
(arrows). C) Total neurite length values indicate that GSK-3ß inhibition upon plating 
results in neurites shorter than in control, whereas GSK-3ß inhibition from DIV2-3 
stimulates neurite extension (Bar = 130 µm) (* p≤ 0.05 and *** p≤ 0.001; n=4) 
 
Figure 6. ß-catenin is required for the Wnt-3a- and Wnt-3-induced neurite 
extension of SCNP-derived neurons. A) Western blot showing ß-catenin levels in 
non-infected (NI), expressing scrambled shRNA (scr) or ß-catenin shRNA (sh) #2 and 
#1 SCNP cultures at 5DIV. ß-actin was used as loading control. B) βIII-tubulin-
immunostained SCNP-derived neurons expressing scrambled or ß-catenin shRNA2 
treated with Wnt-3a or Wnt-3 (Bar = 40 µm). C) Total neurite length values indicate 
that Wnt-3a and Wnt-3 stimulate neurite outgrowth in spinal neurons expressing 
scrambled shRNA, but not upon expression of ß-catenin shRNAs (* p≤ 0.05; n=3).   
  
Figure 7. TCF4-driven transcription is required for the Wnt-induced neurite 
outgrowth of spinal neurons. A) Co-treatment with ActD blocks the Wnt-3a- and 
Wnt-3-induced increase in neurite length in SCNP-derived neurons immunostained for 
βIII-tubulin. B) SCNP-derived neurons expressing EGFP (control) or EGFP plus ∆N-
TCF4 treated with Wnt-3 (Bar = 65 µm). C) Neurite length values normalized to 
controls show that ∆N-TCF4 blocks the Wnt-induced neurite extension observed in 
controls (* p≤ 0.05 and ** p≤ 0.01; n=3). 
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Figure 1. Wnt-3a and Wnt-3 produce a sustained or transient increase of SCNP proliferation. A) 
Increase in the percentage of SCNP in S phase in Wnt-treated cells normalized to controls at 2DIV. 
B) SCNP cultures treated with Wnt-3 and immunostained for nestin show increased numbers of 
neural precursors that incorporate BrdU at 2DIV (asterisks). Arrows point to small neuroblasts. 
(Bar= 65 µm). C) BrdU incorporation in small neuroblasts (left panels) and in total SCNP (right 
panels) show that Wnt-3a and Wnt-3 increase proliferation at 2DIV. However at 4DIV only Wnt-3a 
maintains SCNP proliferation. D) Expression levels of p57 and p27 Cdk inhibitors in SCNP treated 
with Wnt-3a or Wnt-3 normalized to the respective controls show decreased levels of p57 and p27 
following Wnt-3a treatment and increased levels of p57 upon Wnt-3 treatment at 4DIV. The ratio 
Wnt-3/Wnt-3a illustrates the increase of Cdk inhibitors expression by Wnt-3 compared to the effect 
of Wnt-3a. (* p≤ 0.05, ** p≤ 0.01 and *** p≤ 0.001; n=3-5).  
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Figure 2. Wnt-3 increases neurogenesis by canonical Wnt/ß-catenin signaling. A) Wnt-3, but not 
Wnt-3a, increases the percentage of ßIII-tubulin-positive SCNP-derived neurons at 4DIV. Wnt-3-
treated SCNP cultures show increased number of ßIII-tubulin-immunoreactive neurons referred to 
the total number of cells (stained by Hoechst) compared to control (Bar= 65 µm). B) The 
neurogenesis induced by Wnt-3 treatment (3-5DIV) in SCNP expressing scrambled shRNA is 
abolished by β-catenin shRNA. C) Wnt-3 increases neurite extension in SCNP-derived post-mitotic 
neurons, co-immunostained for ßIII-tubulin and the transcription factor NeuN at 4DIV (Bar= 40 µm) 
(* p≤ 0.05, ** p≤ 0.01 and *** p≤ 0.001; n=3-4).  
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Figure 3.  Wnt-3a and Wnt-3 induce neurite outgrowth in SCNP-derived neurons. A, B) Wnt-3a and 
Wnt-3 increase neurite extension compared to controls at 2DIV and 4DIV (Bar= 40 µm). C, D) Total 
neurite length values for control and Wnt-treated SCNP-derived neurons at 2DIV and 4DIV (** p≤ 
0.01 and *** p≤ 0.001; n=4-6).  
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Figure 4. Effects of Dkk-1 and Fz-8/Fc on neurogenesis and neurite outgrowth at 4DIV. A) Wnt-3 
(bottom) but not Wnt-3a (top) increase neurogenesis (estimated as the % of βIII-tubulin-positive 
neurons) from SCNP, which is partially inhibited by high doses of Dkk-1 and Fz-8/Fc. B) Fz-8/Fc 
alone or together with Dkk-1 block the increase in neurite extension induced by Wnt-3a (top) and 
Wnt-3 (bottom), pointing at the specificity of the Wnt effects (* p≤0.05, **, p≤0.01, *** p≤0.001 
when comparing to the corrresponding control; $ p≤0.05, $$ p≤0.01 when comparing to Wnt-
treatment without Dkk-1 and Fz-8/Fc; n=3-4). Note the decreased neurite extension obtained upon 
Fz-8/Fc treatment in the absence of exogenous Wnt-3a, suggesting the role of endogenous Wnts in 
this process.  
294x203mm (600 x 600 DPI)  
 
Page 28 of 31
Journal of Neuroscience Research
Journal of Neuroscience Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
  
 
 
Figure 5. GSK-3ß inhibition upon plating reduces neurite outgrowth, whereas later GSK-3ß inhibition 
mimics the Wnt-induced neurite extension in SCNP-derived neurons. A) Schematic representation of 
the canonical Wnt/β-catenin pathway. 
Wnt binding to the Fz-LRP5/6 receptor complex recruits Dvl and results in the inhibition of GSK3-β, 
disassembly of the destruction complex involving GSK3-β, β-catenin, APC, Axin and CK1 and 
accumulation of β-catenin in the cytosol that avoids degradation. β-catenin nuclear translocation 
and transcriptional regulation of TCF/LEF target genes. A branch of the pathway diverges at the 
level of GSK3-β and regulates the cytoskeleton independent of β-catenin (Ciani and Salinas 2005; 
Sanchez-Camacho and Bovolenta 2009). B) SCNP were treated with Bio and Kenpaullone from 
plating (DIV0-3) or overnight on pre-established adherent cultures (DIV2-3). Note the short 
processes of SCNP-derived neurons immunostained for βIII-tubulin treated with Bio from plating 
(arrows). C) Total neurite length values indicate that GSK-3ß inhibition upon plating results in 
neurites shorter than in control, whereas GSK-3ß inhibition from DIV2-3 stimulates neurite 
extension (Bar = 130 µm) (* p≤ 0.05 and *** p≤ 0.001; n=4) 
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Figure 6. ß-catenin is required for the Wnt-3a- and Wnt-3-induced neurite extension of SCNP-
derived neurons. A) Western blot showing ß-catenin levels in non-infected (NI), expressing 
scrambled shRNA (scr) or ß-catenin shRNA (sh) #2 and #1 SCNP cultures at 5DIV. ß-actin was used 
as loading control. B) βIII-tubulin-immunostained SCNP-derived neurons expressing scrambled or 
ß-catenin shRNA2 treated with Wnt-3a or Wnt-3 (Bar = 40 µm). C) Total neurite length values 
indicate that Wnt-3a and Wnt-3 stimulate neurite outgrowth in spinal neurons expressing scrambled 
shRNA, but not upon expression of ß-catenin shRNAs (* p≤ 0.05; n=3).    
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Figure 7. TCF4-driven transcription is required for the Wnt-induced neurite outgrowth of spinal 
neurons. A) Co-treatment with ActD blocks the Wnt-3a- and Wnt-3-induced increase in neurite 
length in SCNP-derived neurons immunostained for βIII-tubulin. B) SCNP-derived neurons 
expressing EGFP (control) or EGFP plus ∆N-TCF4 treated with Wnt-3 (Bar = 65 µm). C) Neurite 
length values normalized to controls show that ∆N-TCF4 blocks the Wnt-induced neurite extension 
observed in controls (* p≤ 0.05 and ** p≤ 0.01; n=3).  
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